Genus PLC (FRA:GBE)

€ 21 -1.6 (-7.08%) Market Cap: 1.43 Bil Enterprise Value: 1.72 Bil PE Ratio: 36.48 PB Ratio: 2.14 GF Score: 79/100

Half Year 2024 Genus PLC Earnings Call Transcript
Feb 22, 2024

€21.24 (+1.14%)

Earnings
Full Year 2023 Genus PLC Earnings Presentation (Q&A) Transcript
Sep 07, 2023
Full Year 2023 Genus PLC Pre- Recorded Earnings Presentation Transcript
Sep 07, 2023
Half Year 2023 Genus PLC Earnings Call Transcript
Feb 23, 2023

€29.4

Earnings
Half Year 2023 Genus PLC Pre-Recorded Earnings Presentation Transcript
Feb 23, 2023
Full Year 2022 Genus PLC Earnings Presentation (Q&A Session) Transcript
Sep 08, 2022
Full Year 2022 Genus PLC Earnings Presentation Transcript
Sep 08, 2022
Half Year 2022 Genus PLC Earnings Presentation (Q&A Session) Transcript
Feb 24, 2022
Half Year 2022 Genus PLC Earnings Presentation (Pre-Recorded) Transcript
Feb 24, 2022
Full Year 2021 Genus PLC Earnings Presentation - Q&A Session Transcript
Sep 09, 2021
Full Year 2021 Genus PLC Earnings Presentation (Pre-recorded) Transcript
Sep 09, 2021
Genus PLC Capital Markets Day Transcript
Jun 22, 2021
Interim 2021 Genus PLC Earnings Call Transcript
Feb 25, 2021

€60.5 (+0.83%)

Earnings
Preliminary Q4 2020 Genus PLC Earnings Presentation (Pre-Recorded Analysts and Bankers Briefing) Transcript
Sep 08, 2020
Interim 2020 Genus PLC Earnings Presentation Transcript
Feb 27, 2020
Preliminary 2019 Genus PLC Earnings Presentation Transcript
Sep 05, 2019
Interim 2019 Genus PLC Earnings Presentation Transcript
Feb 28, 2019

Genus PLC Capital Markets Day Transcript

Jun 22, 2021 / 02:00PM GMT

Release Date Price: €56.5 (-3.42%)

Transcript

Stephen Wilson

Genus plc - CEO & Executive Director

Welcome to the Genus Capital Markets Event 2021. We really appreciate you spending some time with us, and we hope that you find these sessions we have for you this afternoon engaging and informative. We've got a series of presentations for you today which members of our Genus executive leadership team will be making, and we're going to have the whole team present for a live question-and-answer session after the presentations.

I'm going to pass over the usual disclaimer slide and move to a chart here which tries to put into context what we're going to be talking about today. Those of you who followed the company for some time are probably familiar with how we've talked about our business model, which you see on the right. At its center is the delivery of genetic improvement. That's our core focus. And it's illustrated on this chart by the genetic distribution curve, which you can see here shifting to the right. Today, we do this in 3 protein markets: pork, dairy and beef. And we achieve this genetic improvement through our R&D activities

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.